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Wednesday, February 6, 2013 561athe folded length of cytochrome b562 in its reduced state. This novel observa-
tion could be the basis of heme protein-based ‘‘piezoelectric-like’’ nanomate-
rials and actuators.
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Bacterial diheme cytochrome c peroxidases form part of the detoxification
pathways in the periplasmic space that convert hydrogen peroxide to water.
The turnover of peroxide requires a two-electron reduction, and these reducing
equivalents must be delivered to the peroxidase by soluble electron transfer
proteins. This study focuses on the electron transfer complexes formed between
the diheme cytochrome c peroxidase from Shewanella oneidensis (So CcP) and
its native electron donor ScyA. Due to the transient nature of this interaction
and its presumed dependence on redox state of the two binding partners, tradi-
tional biophysical analysis of this system has proved challenging. Here, we re-
port the use of RosettaDock to predict the protein-protein interaction surfaces
on So CcP when in the inactive, oxidized state and the active, semi-reduced
state. We validate these models by generating site-directed mutants designed
to interfere with specific hydrophobic interfaces suggested in the docking anal-
ysis and measuring their kinetic competence for both single-electron reductive
activation and two-electron peroxide turnover. These results suggest how
redox-driven changes in So CcP conformation regulate protein-protein
interactions.
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Cytochrome P450 proteins (CYPs) constitute a large group of enzymes in-
volved in the metabolism of a large number of endogenous compounds and xe-
nobiotics. In humans, CYP3A4 is the most abundant isoform, which is
responsible for the metabolism of more than 50% of clinically used drugs. It
has been suggested that the interaction of CYPs with the membrane is crucial
for the binding of liposoluble substrates to the active site of the enzyme.
Molecular dynamics simulations using a HMMM membrane model have cap-
tured spontaneous insertion of the globular domain of CYP3A4 into the mem-
brane and revealed a significant reconfiguration of the access tunnels leading to
the active site upon membrane binding. We have identified that the binding to
the membrane favors the opening of several access tunnels to the active site not
observed in the crystallographic structures. Rearrangement of a Phe-cluster ap-
pears to be the main membrane-induced event resulting in the opening of the
access tunnels. Given the location of these tunnels, they might be involved in
leading compounds in or out of the active site. In order to characterize the
role of these access tunnels in access/egress of compounds, we have also per-
formed steered molecular dynamics simulations to pull progesterone from the
active site of the membrane-bound CYP3A4. Parameters for progesterone were
optimized employing the Force Field Toolkit recently developed by our group.
We tested 5 different tunnels, previously identified to be open when CYP3A4 is
bound to the membrane. To complement the SMD simulations, the partitioning
of progesterone into the membrane was also studied. The results of these sim-
ulations allow us to elucidate the role of the membrane in the access/egress of
compounds to the active site of CYP3A4.
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GlbN is a monomeric 2/2 hemoglobin found in several cyanobacteria. Physio-
logical data suggest that, in Synechococcus sp. PCC 7002, GlbN protects the
cell from damage associated with nitrate metabolism [1]. Under reducing con-
ditions, GlbN undergoes a facile posttranslational cross-linking between
His117 and the heme 2-vinyl. In a study of the enzymatic and chemical prop-
erties of GlbN, the solution structure of the protein in the ferric, bis-histidine
state with heme posttranslational modification was determined by NMR
methods. As this protein is paramagnetic (S = 1/2) and can be prepared inthe reduced state (S = 0), heme methyl hyperfine chemical shifts were used
to determine the orientation of the ligating histidines, and proton pseudocontact
shifts were applied in the refinement. The NMRmodel contains regions that ap-
pear to sample multiple conformations, specifically the A helix and EF loop.
Here we present the X-ray structure of GlbN. Crystals were obtained by the va-
por diffusion hanging drop method, and data were collected under cryogenic
conditions (National Synchrotron Light Source, BNL). The structure of the re-
lated Synechocystis sp. PCC 6803 GlbN (1RTX) was used as the search model
for molecular replacement. Iterative model building yielded a final structure at
1.65 A˚ resolution. The X-ray data revealed a ruffled heme, provided a reliable
representation of its environment in solution, and allowed for an assessment of
the paramagnetic NMR approach. The X-ray data also gave an indication of the
effect of crystal packing on the flexible regions of GlbN. Comparison with the
SynechocystisGlbN structure highlighted the resilience of the 2/2 globin fold as
well as subtle differences in the solvent accessibility of the heme active site.
[1] Scott et al. (2010) Biochemistry 49:7000
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We have designed and engineered a non-natural heme binding protein maquette
with diverse heme ligations (bis-his, his-cys, single cys) and dramatically dif-
ferent spectroscopic and redox properties. Hemoproteins in nature perform di-
versified functions such as oxygen storage, oxygen transport, CO, NO
signaling, gene regulation, drug metabolism. Hemoproteins achieve these di-
versified functions by modifying the redox properties of heme prosthetic group
and by altered ligating amino acid to the central Fe metal or by use of different
tetrapyrroles or by the nature of amino acids in the vicinity of heme. We have
successfully designed a single chain tetra-helix bundle hemoproteins with bis-
his, his-cys and single cys ligations, all display native absorption spectra of
neuroglobin, CooA (transcription activator), other CO sensing enzymes and cy-
tochrome P450 respectively. All these designed proteins form stable oxyferrous
state with natural and synthetic iron porphyrins. These protein maquettes are
readily expressable in E.coli. and holds great promise for doing P450 kind of
reactions.
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Essentially all hemoglobins (Hbs) bind b heme reversibly, but notable excep-
tions are found in cyanobacterial 2/2 (‘‘truncated’’) Hbs. In the FeII state, the
Hb from Synechocystis sp. PCC 6803 (GlbN) undergoes a posttranslational
modification (PTM) in which a non-iron-coordinating histidine (H117) adds
across the heme 2-vinyl. Heme PTMs alter the chemical properties of the pros-
thetic group and, as such, warrant investigation. The rarity of the histidine-
heme crosslink in heme proteins adds interest to the PTM determinants.
Here, we examined the robustness of the nucleophilic addition with amino
acid replacements. We applied absorbance and NMR spectroscopies to charac-
terize the products.
We generated two GlbN variants. The first, H117A/L79H GlbN, was designed
to eliminate PTM at the 2-vinyl and explore reactivity on the 4-vinyl side of the
heme. Insertion of a histidine at position 79 caused a severe decrease in ferric
heme affinity. Despite this, reduction to the FeII state resulted in a PTM iden-
tical to that observed with H117 in the wild-type protein. Remarkably, the sec-
ond variant, L79H GlbN, exhibited reactivity at both the 2- and 4-heme vinyls,
demonstrating a lack of stringent electronic requirements for the reaction.
To test crosslink formation further, we used the 2/2 Hb from Chlamydomona-
seugametos (Ce-Hb), which compared to GlbN has a similar fold, only 45% se-
quence identity, and distinct heme environment in the ligand-free state. We
engineered histidine residues at the topological equivalents of H117 and L79
in GlbN (T111 and L75). With changes to the GlbN protocol involving the dis-
tal ligand, evidence for reductive heme modification was detected in both Ce
Hb variants. The data suggested strongly that properly positioned histidines
can cause heme PTM in hemoglobins.
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